GW Pharma says Sativex gets Canadian approval

GW Pharma says Sativex gets Canadian approval


Tue Aug 7, 2007 7:16 AM BST135


LONDON, Aug 7 (Reuters) - Britain's GW Pharmaceuticals Plc (GWP.L: Quote, Profile , Research) said on Tuesday that Canada's federal health department, Health Canada, had approved its cannabis-based medicine Sativex for treatment of cancer patients.

The treatment will be used by advanced cancer patients suffering from moderate to severe pain, GW said.

Last month GW announced a delay for the possible roll-out of the treatment in Europe after drug regulators requested a further clinical study.

© Reuters 2007. All Rights Reserved.

http://investing.reuters.co.uk/news/articleinvesting.aspx?type=smallCapsNews&storyID=2007-08-07T061558Z_01_WLB0258_RTRIDST_0_GWPHARMA-CANADA-URGENT.XML


DaBronx